VistaGen Therapeutics Updates Executive Severance and Control Plan
at www.tipranks.com (Fri, 9-Oct 5:52 PM)
VTGN rises after fasedienol open-label extension shows 1.6% AE discontinuation and LSAS improvement through Month 4
Market Chameleon (Wed, 23-Sep 9:54 AM)
SRX Global Takes a Strategic Stake in Vistagen Therapeutics—A Fresh Vote of Confidence in Neuroscience Innovation
Market Chameleon (Tue, 4-Aug 10:36 AM)
